Zenocutuzumab Antibody
Zenocutuzumab (MCLA-128) is a bispecific antibody that inhibits the HER2/HER3 heterodimerization driven by NRG1 fusions. It is a research tool for studying NRG1-rearranged cancers, with utility demonstrated in both in vitro cell-based assays and in vivo xenograft models.
Product Specifications
Product Name Alternative
PB4188, PB 4188, MCLA128, MCLA-128, R040517, R 040517
Target
EGFR, HER
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
10.013 mg/mL
Purity
97.00% (May vary between batches)
Molecular Weight
145.76 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY400453 100 µg
AdSS 2 (ADSS) (NM_001126) Human Over-expression Lysate
Sign In for Pricing
View Details 
![4-[2’-(7’’-Deazaguanine)ethyl]benzoic Acid N-Hydroxysuccinimide Ester](https://cdn.genprice.uk/products/572/6294841000630/imageurl/trc-d201350-25mg.webp)
TRC-D201350-25MG 25 mg
4-[2’-(7’’-Deazaguanine)ethyl]benzoic Acid N-Hydroxysuccinimide Ester
Sign In for Pricing
View Details 